Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 Studies

por Kircik, Leon, Fowler, Joseph, Weiss, Jonathan, Meng, Xiangyi, Guana, Adriana, Nyirady, Judit
Publicado 2016

Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies

por Menter, Alan, Cather, Jennifer C., Jarratt, Michael, Meng, Xiangyi, Guana, Adriana, Nyirady, Judit
Publicado 2016

Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies

por Pariser, David, Frankel, Ellen, Schlessinger, Joel, Poulin, Yves, Vender, Ronald, Langley, Richard G., Meng, Xiangyi, Guana, Adriana, Nyirady, Judit
Publicado 2017

Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials

por Adsit, Sandra, Zaldivar, Enrique Rivas, Sofen, Howard, Dei-Cas, Ignacio, Maldonado-García, César, Peñaranda, Elkin O., Puig, Luís, Meng, Xiangyi, Fox, Todd, Guana, Adriana
Publicado 2017

Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials

por Adsit, Sandra, Zaldivar, Enrique Rivas, Sofen, Howard, Dei-Cas, Ignacio, Maldonado-García, César, Peñaranda, Elkin O., Puig, Luís, Meng, Xiangyi, Fox, Todd, Guana, Adriana
Publicado 2017